116 related articles for article (PubMed ID: 22099371)
1. Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?
Tillmann HL; Zachou K; Dalekos GN
Liver Int; 2012 Apr; 32(4):544-53. PubMed ID: 22099371
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience.
Tillmann HL; Hadem J; Leifeld L; Zachou K; Canbay A; Eisenbach C; Graziadei I; Encke J; Schmidt H; Vogel W; Schneider A; Spengler U; Gerken G; Dalekos GN; Wedemeyer H; Manns MP
J Viral Hepat; 2006 Apr; 13(4):256-63. PubMed ID: 16611192
[TBL] [Abstract][Full Text] [Related]
3. [Acute hepatitis B: is antiviral therapy indicated? Two case reports].
Girke J; Wedemeyer H; Wiegand J; Manns MP; Tillmann HL
Dtsch Med Wochenschr; 2008 May; 133(22):1178-82. PubMed ID: 18491273
[TBL] [Abstract][Full Text] [Related]
4. Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
Leemans WF; Niesters HG; van der Eijk AA; Janssen HL; Schalm SW; de Man RA
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):773-7. PubMed ID: 18617782
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort.
Alvarez-Uria G; Ratcliffe L; Vilar J
HIV Med; 2009 May; 10(5):269-73. PubMed ID: 19210695
[TBL] [Abstract][Full Text] [Related]
6. Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients.
Lee WC; Wu MJ; Cheng CH; Chen CH; Shu KH; Lian JD
Am J Kidney Dis; 2001 Nov; 38(5):1074-81. PubMed ID: 11684562
[TBL] [Abstract][Full Text] [Related]
7. Tenofovir therapy for lamivudine resistance following liver transplantation.
Neff GW; Nery J; Lau DT; O'Brien CB; Duncan R; Shire NJ; Ruiz P; Nery C; Montalbano M; Muslu H; Safdar K; Schiff ER; Tzakis AG; Madariaga JR
Ann Pharmacother; 2004 Dec; 38(12):1999-2004. PubMed ID: 15507498
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response.
Jain MK; Comanor L; White C; Kipnis P; Elkin C; Leung K; Ocampo A; Attar N; Keiser P; Lee WM
J Viral Hepat; 2007 Mar; 14(3):176-82. PubMed ID: 17305883
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of entecavir and/or tenofovir for prophylaxis and treatment of hepatitis B recurrence post-liver transplant.
Jiménez-Pérez M; Sáez-Gómez AB; Mongil Poce L; Lozano-Rey JM; de la Cruz-Lombardo J; Rodrigo-López JM
Transplant Proc; 2010 Oct; 42(8):3167-8. PubMed ID: 20970638
[TBL] [Abstract][Full Text] [Related]
10. Late onset of hepatitis B virus reactivation following hematopoietic stem cell transplantation: successful treatment with combined entecavir plus tenofovir therapy.
Milazzo L; Corbellino M; Foschi A; Micheli V; Dodero A; Mazzocchi A; Montefusco V; Zehender G; Antinori S
Transpl Infect Dis; 2012 Feb; 14(1):95-8. PubMed ID: 21749588
[TBL] [Abstract][Full Text] [Related]
11. Entecavir for the treatment of chronic hepatitis B virus infection.
Matthews SJ
Clin Ther; 2006 Feb; 28(2):184-203. PubMed ID: 16678641
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis.
Hyun JJ; Seo YS; Yoon E; Kim TH; Kim DJ; Kang HS; Jung ES; Kim JH; An H; Kim JH; Yim HJ; Yeon JE; Lee HS; Byun KS; Um SH; Kim CD; Ryu HS
Liver Int; 2012 Apr; 32(4):656-64. PubMed ID: 22099071
[TBL] [Abstract][Full Text] [Related]
13. Lamivudine treatment for acute severe hepatitis B: a pilot study.
Schmilovitz-Weiss H; Ben-Ari Z; Sikuler E; Zuckerman E; Sbeit W; Ackerman Z; Safadi R; Lurie Y; Rosner G; Tur-Kaspa R; Reshef R
Liver Int; 2004 Dec; 24(6):547-51. PubMed ID: 15566503
[TBL] [Abstract][Full Text] [Related]
14. Response to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavir.
Pan CQ; Hu KQ; Yu AS; Chen W; Bunchorntavakul C; Reddy KR
J Viral Hepat; 2012 Mar; 19(3):213-9. PubMed ID: 22329376
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of entecavir in lamivudine-refractory patients with chronic hepatitis B: randomized controlled trial in Japanese patients.
Suzuki F; Toyoda J; Katano Y; Sata M; Moriyama M; Imazeki F; Kage M; Seriu T; Omata M; Kumada H
J Gastroenterol Hepatol; 2008 Sep; 23(9):1320-6. PubMed ID: 18554238
[TBL] [Abstract][Full Text] [Related]
16. The use of lamivudine for patients with acute hepatitis B (a series of cases).
Kondili LA; Osman H; Mutimer D
J Viral Hepat; 2004 Sep; 11(5):427-31. PubMed ID: 15357647
[TBL] [Abstract][Full Text] [Related]
17. Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.
Quiros-Roldan E; Calabresi A; Lapadula G; Tirelli V; Costarelli S; Cologni G; Zaltron S; Puoti M; Carosi G; Torti C
Antivir Ther; 2008; 13(3):341-8. PubMed ID: 18572746
[TBL] [Abstract][Full Text] [Related]
18. Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients.
Benhamou Y; Fleury H; Trimoulet P; Pellegrin I; Urbinelli R; Katlama C; Rozenbaum W; Le Teuff G; Trylesinski A; Piketty C;
Hepatology; 2006 Mar; 43(3):548-55. PubMed ID: 16496322
[TBL] [Abstract][Full Text] [Related]
19. Treatment of severe, nonfulminant acute hepatitis B with lamivudine vs placebo: a prospective randomized double-blinded multicentre trial.
Wiegand J; Wedemeyer H; Franke A; Rößler S; Zeuzem S; Teuber G; Wächtler M; Römmele U; Ruf B; Spengler U; Trautwein C; Bock CT; Fiedler GM; Thiery J; Manns MP; Brosteanu O; Tillmann HL;
J Viral Hepat; 2014 Oct; 21(10):744-50. PubMed ID: 24329913
[TBL] [Abstract][Full Text] [Related]
20. Treatment of fulminant acute Hepatitis B with nucles(t)id analogues is safe and does not lead to secondary chronification of Hepatitis B.
Jochum C; Maischack F; Anastasiou OE; Verheyen J; Timm J; Bechmann L; Gerken G; Canbay A
Z Gastroenterol; 2016 Dec; 54(12):1306-1311. PubMed ID: 27936480
[No Abstract] [Full Text] [Related]
[Next] [New Search]
